1-[(4-Chlorophenyl)methyl]-N-(4-ethoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

Catalog No. :
ACDXPC580
CAS No. :
400077-76-1
Molecular Formula :
C21H19ClN2O3
Molecular Weight :
382.85

IUPAC Name:1-(4-chlorobenzyl)-N-(4-ethoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

1-[(4-Chlorophenyl)methyl]-N-(4-ethoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$284.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(4-Chlorophenyl)methyl]-N-(4-ethoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide
IUPAC Name1-(4-chlorobenzyl)-N-(4-ethoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide
MDL No.MFCD01936118
Molecular FormulaC21H19ClN2O3
Molecular Weight382.85
SMILESO=C(C1=CC=CN(CC2=CC=C(Cl)C=C2)C1=O)NC3=CC=C(OCC)C=C3
InChI KeyZUSYCVPNTLBEFY-UHFFFAOYSA-N
Synonym1-[(4-chlorophenyl)methyl]-N-(4-ethoxyphenyl)-2-oxopyridine-3-carboxamide;3-Pyridinecarboxamide, 1-[(4-chlorophenyl)methyl]-N-(4-ethoxyphenyl)-1,2-dihydro-2-oxo-
CAS No.400077-76-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACDXPC580 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSZPC617 route compound structure diagram
    ACSZPC617637-56-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDXPC580 route product structure diagram
    ACDXPC580400077-76-1
Inquiry

2. ACDXPC580 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDXPC580 route product structure diagram
    ACDXPC580400077-76-1
Inquiry

Comments (0)